Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
| Market Cap | 3.86B | P/E | - | EPS this Y | 62.70% | Ern Qtrly Grth | - |
| Income | -119.54M | Forward P/E | 96.86 | EPS next Y | 215.80% | 50D Avg Chg | 7.00% |
| Sales | 455.66M | PEG | 0.38 | EPS past 5Y | - | 200D Avg Chg | 13.00% |
| Dividend | N/A | Price/Book | 37.46 | EPS next 5Y | -147.10% | 52W High Chg | -2.00% |
| Recommedations | 1.80 | Quick Ratio | 2.05 | Shares Outstanding | 296.59M | 52W Low Chg | 49.00% |
| Insider Own | 0.74% | ROA | -2.15% | Shares Float | 238.86M | Beta | 0.69 |
| Inst Own | 107.66% | ROE | -97.94% | Shares Shorted/Prior | 22.81M/24.04M | Price | 13.56 |
| Gross Margin | 89.88% | Profit Margin | -26.23% | Avg. Volume | 2,768,937 | Target Price | 17.36 |
| Oper. Margin | 11.82% | Earnings Date | Nov 6 | Volume | 1,757,132 | Change | 1.12% |
About Amicus Therapeutics, Inc.
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant; and Pombiliti + Opfolda, for the treatment of late onset. It has collaboration and license agreements with the University of Pennsylvania to research and develop parvovirus gene therapy products; and GlaxoSmithKline. Amicus Therapeutics, Inc. was incorporated in 2002 and is headquartered in Princeton, New Jersey.
Amicus Therapeutics, Inc. News
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Campbell Bradley L | President and CEO President and CEO | Feb 01 | Sell | 12.56 | 15,833 | 198,862 | 875,386 | 02/05/24 |
| Campbell Bradley L | President and CEO President and CEO | Feb 01 | Option | 10.45 | 15,833 | 165,455 | 891,219 | 02/05/24 |
| Crowley John F | Executive Chairman Executive Chairman | Feb 01 | Sell | 12.62 | 31,614 | 398,969 | 750,838 | 02/05/24 |
| Crowley John F | Executive Chairman Executive Chairman | Jan 22 | Sell | 12.3621 | 55,327 | 683,958 | 782,452 | 01/24/24 |
| Crowley John F | Executive Chairman Executive Chairman | Jan 09 | Sell | 13.65 | 31,614 | 431,531 | 869,393 | 01/11/24 |
| Clark David Michael | Chief People Officer Chief People Officer | Jan 08 | Sell | 14 | 10,110 | 141,540 | 266,705 | 01/09/24 |
| Prout Samantha | Chief Accounting Off.. Chief Accounting Officer | Jan 08 | Sell | 14 | 32,104 | 449,456 | 80,953 | 01/09/24 |
| Campbell Bradley L | President and CEO President and CEO | Jan 02 | Sell | 14.23 | 15,833 | 225,304 | 947,805 | 01/04/24 |
| Campbell Bradley L | President and CEO President and CEO | Jan 02 | Option | 10.45 | 15,833 | 165,455 | 956,138 | 01/04/24 |
| Rosenberg Ellen | Chief Legal Officer Chief Legal Officer | Jan 02 | Sell | 14.21 | 30,000 | 426,300 | 342,285 | 01/04/24 |
| Rosenberg Ellen | Chief Legal Officer Chief Legal Officer | Jan 02 | Option | 5.16 | 30,000 | 154,800 | 372,285 | 01/04/24 |
| Castelli Jeff | Chief Development Of.. Chief Development Officer | Dec 28 | Sell | 14.5171 | 17,421 | 252,902 | 340,661 | 12/29/23 |
| Prout Samantha | Chief Accounting Off.. Chief Accounting Officer | Dec 26 | Sell | 14.0003 | 7,659 | 107,228 | 121,912 | 12/28/23 |
| Rosenberg Ellen | Chief Legal Officer Chief Legal Officer | Dec 26 | Sell | 14.03 | 35,000 | 491,050 | 342,285 | 12/28/23 |
| Rosenberg Ellen | Chief Legal Officer Chief Legal Officer | Dec 26 | Option | 5.16 | 35,000 | 180,600 | 347,285 | 12/28/23 |
| Castelli Jeff | Chief Development Of.. Chief Development Officer | Dec 18 | Sell | 13.18 | 19,154 | 252,450 | 358,082 | 12/20/23 |
| Crowley John F | Executive Chairman Executive Chairman | Dec 15 | Sell | 12.66 | 6,043 | 76,504 | 877,748 | 12/19/23 |
| Crowley John F | Executive Chairman Executive Chairman | Dec 01 | Sell | 11.0800 | 6,043 | 66,956 | 883,791 | 12/05/23 |
| Crowley John F | Executive Chairman Executive Chairman | Nov 15 | Sell | 10.8385 | 6,043 | 65,497 | 889,834 | 11/17/23 |
| Campbell Bradley L | President and CEO President and CEO | Nov 01 | Sell | 10.97 | 11,700 | 128,349 | 792,161 | 11/03/23 |
| Campbell Bradley L | President and CEO President and CEO | Nov 01 | Option | 2.94 | 11,700 | 34,398 | 803,861 | 11/03/23 |
| Crowley John F | Executive Chairman Executive Chairman | Nov 01 | Sell | 10.9741 | 6,044 | 66,327 | 895,877 | 11/03/23 |
| Crowley John F | Executive Chairman Executive Chairman | Oct 16 | Sell | 10.4979 | 6,044 | 63,449 | 901,921 | 10/18/23 |
| Crowley John F | Executive Chairman Executive Chairman | Oct 02 | Sell | 11.39 | 6,044 | 68,841 | 907,965 | 10/04/23 |
| Campbell Bradley L | President & CEO President & CEO | Oct 02 | Option | 2.94 | 11,700 | 34,398 | 803,861 | 10/04/23 |
| Campbell Bradley L | President & CEO President & CEO | Oct 02 | Sell | 11.62 | 11,700 | 135,954 | 792,161 | 10/04/23 |
| Crowley John F | Executive Chairman Executive Chairman | Sep 15 | Sell | 13.0648 | 6,044 | 78,964 | 914,009 | 09/18/23 |
| Crowley John F | Executive Chairman Executive Chairman | Sep 01 | Sell | 12.9794 | 6,044 | 78,447 | 920,053 | 09/06/23 |
| Campbell Bradley L | President & CEO President & CEO | Sep 01 | Sell | 12.97 | 18,093 | 234,666 | 792,161 | 09/06/23 |
| Campbell Bradley L | President & CEO President & CEO | Sep 01 | Option | 2.94 | 11,700 | 34,398 | 810,254 | 09/06/23 |
| Crowley John F | Executive Chairman Executive Chairman | Aug 15 | Sell | 13.0268 | 6,044 | 78,734 | 926,097 | 08/16/23 |
| Prout Samantha | Chief Accounting Off.. Chief Accounting Officer | Aug 09 | Sell | 14.01 | 36,909 | 517,095 | 137,003 | 08/11/23 |
| Prout Samantha | Chief Accounting Off.. Chief Accounting Officer | Aug 09 | Option | 10.43 | 36,909 | 384,961 | 173,912 | 08/11/23 |
| Crowley John F | Executive Chairman Executive Chairman | Jul 17 | Sell | 13.4453 | 6,044 | 81,263 | 938,185 | 07/19/23 |
| Campbell Bradley L | President & CEO President & CEO | Jul 12 | Sell | 12.51 | 8,300 | 103,833 | 806,854 | 07/14/23 |
| Crowley John F | Executive Chairman Executive Chairman | Jul 03 | Sell | 12.3107 | 6,044 | 74,406 | 944,229 | 07/06/23 |
| Campbell Bradley L | President & CEO President & CEO | Jul 03 | Option | 2.94 | 11,700 | 34,398 | 826,854 | 07/06/23 |
| Campbell Bradley L | President & CEO President & CEO | Jul 03 | Sell | 12.31 | 11,700 | 144,027 | 815,154 | 07/06/23 |
| Crowley John F | Executive Chairman Executive Chairman | Jun 01 | Sell | 11.3596 | 6,044 | 68,657 | 956,317 | 06/05/23 |
| Campbell Bradley L | President & CEO President & CEO | Jun 01 | Sell | 11.36 | 11,700 | 132,912 | 823,454 | 06/05/23 |
| Campbell Bradley L | President & CEO President & CEO | Jun 01 | Option | 2.7 | 11,700 | 31,590 | 835,154 | 06/05/23 |
| SBLENDORIO GLENN | Director Director | May 18 | Option | 3.32 | 15,000 | 49,800 | 86,719 | 05/19/23 |
| Crowley John F | Executive Chairman Executive Chairman | May 15 | Sell | 11.1808 | 6,044 | 67,577 | 962,361 | 05/17/23 |
| Crowley John F | Executive Chairman Executive Chairman | Apr 17 | Sell | 11.6648 | 6,044 | 70,502 | 974,449 | 04/19/23 |
| Crowley John F | Executive Chairman Executive Chairman | Apr 03 | Sell | 11.2156 | 6,044 | 67,787 | 980,493 | 04/05/23 |
| Campbell Bradley L | President & CEO President & CEO | Apr 03 | Sell | 11.21 | 11,700 | 131,157 | 823,454 | 04/05/23 |
| Campbell Bradley L | President & CEO President & CEO | Apr 03 | Option | 2.45 | 11,700 | 28,665 | 835,154 | 04/05/23 |
| RAAB MICHAEL | Director Director | Mar 17 | Sell | 11.33 | 4,408 | 49,943 | 60,012 | 03/21/23 |
| RAAB MICHAEL | Director Director | Mar 17 | Option | 3.32 | 15,000 | 49,800 | 64,420 | 03/21/23 |
| Crowley John F | Executive Chairman Executive Chairman | Mar 15 | Sell | 11.3414 | 6,044 | 68,547 | 986,537 | 03/17/23 |